https://www.sciencedaily.com/releases/2021/05/210504112646.htm
https://www.futurity.org/viral-bacterial-infection-antibiotics-2562132/
potential competitor of febridx of Lumos diagnostics
In a multisite study of more than 600 patients presenting to hospital emergency departments with respiratory infections, the tests identified bacterial infections with 80% accuracy and viral infections with nearly 87% accuracy. The current standard tests have about 69-percent accuracy. Tests provided results in less than an hour, and their accuracy was confirmed retrospectively using two different methods.
After the team discovered these gene expression signatures for bacterial and viral infection, they collaborated with BioFire Diagnostics, a company that specializes in molecular diagnostics, to develop this first-of-its kind test.(arrogant Americans)
Should take them some time to get the test on the market, and it's not as good as lumos
- Forums
- ASX - By Stock
- AT1
- AT1 FY21 - General Discussion + FA
AT1 FY21 - General Discussion + FA, page-1709
-
- There are more pages in this discussion • 725 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.5¢ |
Change
-0.001(3.85%) |
Mkt cap ! $15.98M |
Open | High | Low | Value | Volume |
2.6¢ | 2.6¢ | 2.5¢ | $15.57K | 604.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 277067 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 18145 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 235200 | 0.025 |
2 | 150461 | 0.024 |
2 | 493000 | 0.023 |
5 | 438874 | 0.022 |
3 | 555000 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 18145 | 1 |
0.028 | 306666 | 3 |
0.029 | 252248 | 7 |
0.030 | 841593 | 11 |
0.031 | 159930 | 3 |
Last trade - 15.57pm 28/06/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online